HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasuhiro Oki Selected Research

B-Cell Lymphoma (Lymphoma, B Cell)

1/2023Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma.
10/2021Fimepinostat (CUDC-907) in patients with relapsed/refractory diffuse large B cell and high-grade B-cell lymphoma: report of a phase 2 trial and exploratory biomarker analyses.
5/2019Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.
12/2018Positron emission tomography-computed tomography predictors of progression after DA-R-EPOCH for PMBCL.
1/2018Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.
1/2017Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.
5/2015Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography.
3/2015A clinician's guide to double hit lymphomas.
1/2015Novel treatments for T-cell lymphoma.
7/2008Prognostic value of serum soluble interleukin-2 receptor level in patients with diffuse large B cell lymphoma, treated with CHOP- or RCHOP-based therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasuhiro Oki Research Topics

Disease

29Hodgkin Disease (Hodgkin's Disease)
01/2022 - 02/2007
29Lymphoma (Lymphomas)
01/2019 - 08/2005
24Neoplasms (Cancer)
11/2023 - 08/2004
20Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2023 - 07/2008
15Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2018 - 08/2004
10B-Cell Lymphoma (Lymphoma, B Cell)
01/2023 - 07/2008
10T-Cell Lymphoma (Lymphoma, T Cell)
08/2020 - 05/2012
8Neutropenia
11/2018 - 01/2008
7Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
02/2021 - 12/2009
7Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2012 - 02/2006
5Thrombocytopenia (Thrombopenia)
01/2018 - 01/2008
5Disease Progression
01/2016 - 08/2005
4Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
02/2019 - 05/2012
4Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2019 - 12/2009
4Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2018 - 11/2009
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2019 - 11/2014
3Hematologic Neoplasms (Hematological Malignancy)
11/2018 - 02/2007
3Diarrhea
11/2018 - 12/2009
3Anemia
01/2018 - 12/2013
3Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
01/2016 - 01/2007
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
03/2007 - 08/2004
2Fatigue
08/2020 - 12/2013
2Melanoma (Melanoma, Malignant)
01/2019 - 08/2004
2Exanthema (Rash)
11/2018 - 01/2018
2Febrile Neutropenia
01/2018 - 12/2009
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2018 - 01/2010
2Radiation Pneumonitis
12/2016 - 05/2015
2Infections
01/2016 - 12/2013
2Dyspnea (Shortness of Breath)
12/2014 - 12/2013
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
08/2020
1Residual Neoplasm
01/2020
1Mycosis Fungoides
09/2018

Drug/Important Bio-Agent (IBA)

31Rituximab (Mabthera)FDA Link
11/2023 - 01/2008
17Doxorubicin (Adriamycin)FDA LinkGeneric
11/2023 - 05/2012
13Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2023 - 01/2008
11Vincristine (Oncovin)FDA LinkGeneric
11/2023 - 12/2013
9Prednisone (Sone)FDA LinkGeneric
11/2023 - 12/2013
8Brentuximab VedotinIBA
01/2022 - 05/2012
7Bleomycin (Blenoxane)FDA LinkGeneric
01/2022 - 05/2012
7DecitabineFDA Link
10/2012 - 05/2006
6Dacarbazine (DIC)FDA LinkGeneric
01/2022 - 05/2012
6Etoposide (VP 16)FDA LinkGeneric
12/2018 - 01/2008
5Vinblastine (Vinblastine Sulfate)FDA Link
01/2022 - 05/2012
5Methotrexate (Mexate)FDA LinkGeneric
10/2018 - 12/2013
5GemcitabineFDA Link
01/2018 - 02/2008
5Dexamethasone (Maxidex)FDA LinkGeneric
01/2018 - 01/2008
4ibrutinibIBA
01/2023 - 08/2014
4Lenalidomide (CC 5013)FDA Link
01/2023 - 11/2014
4Histone Deacetylases (Histone Deacetylase)IBA
10/2021 - 01/2013
4Histone Deacetylase InhibitorsIBA
02/2021 - 12/2011
4VorinostatFDA Link
11/2020 - 07/2013
4Transaminases (Aminotransferases)IBA
08/2020 - 01/2008
4EnzymesIBA
11/2018 - 01/2010
4Melphalan (Alkeran)FDA LinkGeneric
01/2018 - 12/2009
4Cytarabine (Cytosar-U)FDA LinkGeneric
01/2018 - 01/2008
4DNA (Deoxyribonucleic Acid)IBA
01/2016 - 02/2007
3Biomarkers (Surrogate Marker)IBA
10/2021 - 12/2015
3Immunoconjugates (Immunoconjugate)IBA
02/2019 - 05/2014
3duvelisibIBA
11/2018 - 01/2018
3Bortezomib (Velcade)FDA Link
01/2018 - 02/2016
3Carboplatin (JM8)FDA LinkGeneric
01/2018 - 02/2016
3IfosfamideFDA LinkGeneric
01/2018 - 02/2016
3PanobinostatIBA
01/2018 - 06/2011
3AnthracyclinesIBA
03/2016 - 01/2015
3MethyltransferasesIBA
01/2016 - 02/2007
2Proteins (Proteins, Gene)FDA Link
10/2021 - 03/2015
2EverolimusFDA Link
11/2020 - 12/2013
2Phosphatidylinositols (Phosphatidylinositol)IBA
08/2020 - 01/2018
2romidepsin (FK228)FDA Link
01/2020 - 01/2018
2Immune Checkpoint InhibitorsIBA
01/2019 - 01/2019
2Busulfan (Busulfex)FDA Link
01/2018 - 11/2015
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2018 - 01/2018
2Alanine Transaminase (SGPT)IBA
01/2018 - 01/2018
2Agammaglobulinaemia Tyrosine KinaseIBA
01/2018 - 08/2014
2CUDC-907IBA
11/2017 - 01/2016
2fludarabineIBA
01/2017 - 01/2016
2Azacitidine (5 Azacytidine)FDA Link
01/2016 - 05/2006
2liposomal doxorubicin (Doxil)FDA Link
11/2015 - 03/2015
2Peptides (Polypeptides)IBA
01/2007 - 08/2004
2VaccinesIBA
01/2007 - 08/2004
1Circulating Tumor DNAIBA
11/2023
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
10/2021
1fimepinostatIBA
10/2021
1belinostatIBA
02/2021
1MTOR InhibitorsIBA
11/2020
1Sirolimus (Rapamycin)FDA Link
11/2020
1tenalisibIBA
08/2020
1Immunoglobulins (Immunoglobulin)IBA
01/2020
1MLN 8237IBA
01/2020
1B7-H1 AntigenIBA
01/2019
1pembrolizumabIBA
01/2019
1ParaffinIBA
01/2019
1Formaldehyde (Formol)FDA Link
01/2019
1Aspartate-Ammonia Ligase (Asparagine Synthetase)IBA
01/2018

Therapy/Procedure

30Therapeutics
11/2020 - 01/2007
27Drug Therapy (Chemotherapy)
07/2018 - 02/2006
21Radiotherapy
05/2019 - 06/2014
7Stem Cell Transplantation
01/2018 - 12/2011
3Induction Chemotherapy
10/2018 - 12/2009
2Hematopoietic Stem Cell Transplantation
05/2015 - 12/2011